Brandon Varnell, MD
Payments from drug & device makers
Across 66 payments — averaging $96.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Medtronic$3K
- Johnson & Johnson$142
- W. L. Gore & Associates, Inc.$108
- Endo Pharmaceuticals Inc.$92
- Intra-sana Laboratories$82
- plus $552 from 19 others
What the payments were for
- Consulting fees$2,50039%
- Travel & lodging$1,98231%
- Food & beverage$1,85029%
- Education$150%
- Gifts$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 15 | $2,863 |
| Medtronic | 6 | $2,524 |
| Johnson & Johnson | 2 | $142 |
| W. L. Gore & Associates, Inc. | 3 | $108 |
| Endo Pharmaceuticals Inc. | 6 | $92 |
| Intra-sana Laboratories | 5 | $82 |
| Teleflex LLC | 3 | $81 |
| Merck | 3 | $51 |
| Novo Nordisk | 3 | $50 |
| Stryker | 2 | $44 |
| AbbVie | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Polynovo North America LLC | 1 | $28 |
| Abbott | 1 | $27 |
| Cook Medical LLC | 2 | $26 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Trevena, Inc. | 1 | $23 |
| Apollo Endosurgery US Inc | 1 | $19 |
| Coopersurgical, Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Angiodynamics, Inc. | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $16 |
| Baudax Bio Inc. | 1 | $12 |
| Heron Therapeutics, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,582
- Signia$2,500
- ECHELON ENDOPATH$209
How this compares
$6,363 in reported general payments places this provider in the 75th percentile of 290 surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 118 | $14,073 |
| Famotidine | 150 | $1,654 |
| Omeprazole | 61 | $1,129 |
| Scopolamine | 19 | $793 |
| Ondansetron OdtOndansetron | 48 | $714 |
| Pantoprazole Sodium | 24 | $270 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $259 |
| Ondansetron Hcl | 24 | $124 |
| Cyclobenzaprine Hcl | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Other surgery in Tulsa
- Craig JohnsonTulsa$573K
- Eugene DickensTulsa$456K
- William JenningsTulsa$412K
- Bryce MurrayTulsa$152K
- Jared LepleyTulsa$93K
- Steven FeherTulsa$50K
- Samuel PangburnTulsa$50K
- Ty KirkpatrickTulsa$28K
- John KingTulsa$24K
- Michael ThomasTulsa$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.